Background COVID 19 is an acute respiratory disease caused by infection by the virus
SARS-COV-2 and has been declared as a pandemic whose specific treatment is still not …

The outbreak of the coronavirus disease 2019 (COVID-19) has posed an unprecedented
challenge to the health care communities across the globe. As of December 2020, a total of …

Abstract Coronavirus disease-19 (COVID-19) represents a public health threat worldwide,
and Italy at the present time is considered the epicentre of this severe infection in the …

The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-
2, addressing the preliminary results of passive immunization through convalescent plasma …

Blood from people who have recovered can be a rich source of antibodies, proteins made by
the immune system to attack the virus. The part of the blood that contains antibodies, so …

Letter to the Editor/Transfusion Clinique et Biologique 27 (2020) 165–171 169 indexes such
as blood oxygen saturation improving comprehensively. During the COVID-19 outbreak …

Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life
of several hundred thousand worldwide. However, so far no approved vaccine or drug …

As yet, there is no specific therapy for covid-19. Thus, as an alternative, there is the
transfusion of plasma obtained from individuals who are convalescent from covid-19 …

On March 11th, 2020, the World Health Organization declared COVID‐19 infection as a
pandemic. Since it is a novel virus, there are basically no proven drugs or therapies; …

168 Letter to the Editor/Transfusion Clinique et Biologique 27 (2020) 165–171 tional studies
have stimulated global interest in the organisation of collection systems for this …